A randomized, double-blind, placebo-controlled trial of golimumab+methotrexate versus methotrexate alone in methotrexate-naïve patients with psoriatic arthritis
- Registry ID
- EUCTR2012-005214-19
- Source registry
- EUCTR
- Status
- Completed
- Phase
- PHASE3
- Sponsor
- Academic Medical Center, Department of Rheumatology
- Start date
- 2013-06-20
- Completion date
- 2018-10-18
- Last update
- 2026-08-16
Conditions
- active psoriatic arthritis
Summary
to demonstrate the safety and efficacy of golimumab + MTX versus MTX alone in methotrexaat naïve PsA patients
Locations
View on source registry